MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock
180.93 USD
-0.89 (-0.49%)
180.93 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to MOH. MOH was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of MOH get a neutral evaluation. Nothing too spectacular is happening here. MOH has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
MOH had positive earnings in the past year.
MOH had a negative operating cash flow in the past year.
In the past 5 years MOH has always been profitable.
MOH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.62%, MOH is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 21.07%, MOH belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.98%, MOH belongs to the top of the industry, outperforming 86.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MOH is significantly above the industry average of 9.19%.
The 3 year average ROIC (17.96%) for MOH is well above the current ROIC(11.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROIC | 11.98% |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
1.3 Margins
Looking at the Profit Margin, with a value of 1.98%, MOH is in the better half of the industry, outperforming 61.00% of the companies in the same industry.
MOH's Profit Margin has declined in the last couple of years.
MOH has a Operating Margin (2.97%) which is comparable to the rest of the industry.
MOH's Operating Margin has declined in the last couple of years.
The Gross Margin of MOH (13.91%) is worse than 66.00% of its industry peers.
In the last couple of years the Gross Margin of MOH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% |
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
2. Health
2.1 Basic Checks
MOH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MOH has less shares outstanding than it did 1 year ago.
MOH has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MOH has a worse debt to assets ratio.
2.2 Solvency
MOH has an Altman-Z score of 4.33. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.33, MOH is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
MOH has a Debt/Equity ratio of 0.92. This is a neutral value indicating MOH is somewhat dependend on debt financing.
MOH's Debt to Equity ratio of 0.92 is in line compared to the rest of the industry. MOH outperforms 41.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.33 |
ROIC/WACC1.42
WACC8.46%
2.3 Liquidity
A Current Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
MOH has a Current ratio of 1.68. This is in the better half of the industry: MOH outperforms 65.00% of its industry peers.
A Quick Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
MOH's Quick ratio of 1.68 is fine compared to the rest of the industry. MOH outperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.06%.
MOH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.16% yearly.
The Revenue has grown by 13.65% in the past year. This is quite good.
MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.29% yearly.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
3.2 Future
The Earnings Per Share is expected to grow by 5.04% on average over the next years.
MOH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.09% yearly.
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y5.04%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y6.09%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.81, the valuation of MOH can be described as reasonable.
93.00% of the companies in the same industry are more expensive than MOH, based on the Price/Earnings ratio.
MOH is valuated cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.22 indicates a correct valuation of MOH.
MOH's Price/Forward Earnings ratio is rather cheap when compared to the industry. MOH is cheaper than 86.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MOH to the average of the S&P500 Index (23.98), we can say MOH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.81 | ||
| Fwd PE | 13.22 |
4.2 Price Multiples
MOH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MOH is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.34 |
4.3 Compensation for Growth
MOH has a very decent profitability rating, which may justify a higher PE ratio.
MOH's earnings are expected to decrease with -10.35% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.69
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
5. Dividend
5.1 Amount
MOH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
180.93
-0.89 (-0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.06%
Inst Owner Change0.37%
Ins Owners1.33%
Ins Owner Change1.17%
Market Cap9.30B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price Target172.29 (-4.78%)
Short Float %7.14%
Short Ratio1.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-1.2%
PT rev (3m)-16.03%
EPS NQ rev (1m)-34.65%
EPS NQ rev (3m)-89.71%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-23.58%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.81 | ||
| Fwd PE | 13.22 | ||
| P/S | 0.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.22 | ||
| P/tB | 4.68 | ||
| EV/EBITDA | 0.34 |
EPS(TTM)18.45
EY10.2%
EPS(NY)13.69
Fwd EY7.56%
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.97
OCFYN/A
SpS866.73
BVpS81.54
TBVpS38.7
PEG (NY)N/A
PEG (5Y)0.69
Graham Number183.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.62% | ||
| ROE | 21.07% | ||
| ROCE | 16.11% | ||
| ROIC | 11.98% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 2.97% | ||
| PM (TTM) | 1.98% | ||
| GM | 13.91% | ||
| FCFM | N/A |
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.53 | ||
| Cap/Depr | 56.78% | ||
| Cap/Sales | 0.25% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 4.33 |
F-Score4
WACC8.46%
ROIC/WACC1.42
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y5.04%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y6.09%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.25%
EBIT Next 3Y-9.54%
EBIT Next 5Y3.97%
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%
MOLINA HEALTHCARE INC / MOH FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 5 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 5 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 9.81 and the Price/Book (PB) ratio is 2.22.